Skip to main content

and
  1. Article

    Open Access

    The efficacy and safety of apatinib plus capecitabine in platinum-refractory metastatic and/or recurrent nasopharyngeal carcinoma: a prospective, phase II trial

    Previous studies have shown that monotherapy with apatinib, an oral tyrosine kinase inhibitor, has promising efficacy for treating recurrent or metastatic (RM) nasopharyngeal carcinoma (NPC) patients. In this ...

    Lin-Quan Tang, **ao-Yun Li, Zhi-Ming Li, Zhi-Gang Liu, Miao-Zhen Lin in BMC Medicine (2023)